ICMR transfers 41 technologies at India's largest biomedical innovation, tech transfer event
New Delhi, May 25
The Indian Council of Medical Research on Monday held India's largest biomedical and technology transfer facilitation here and 41 public‑health technologies were transferred to industry partners, an official statement said.
The event marked the establishment of country's first structured platforms dedicated to biomedical innovation showcasing and technology transfer under the ICMR Medical Innovation Patent Mitra initiative.
The initiative aims to translate indigenous biomedical research into accessible, real-world healthcare solutions through strong industry partnerships, the statement from Ministry of Health and Family Welfare said.
Technologies transferred from ICMR institutes and innovators to industry partners include advanced diagnostics, vaccines, medical devices and biomedical solutions addressing critical public health priorities.
Among the technologies transferred were glycoconjugate and recombinant vaccines for Typhoid and Paratyphoid, as well as diagnostic technologies for diseases such as Japanese Encephalitis, Tuberculosis and Mpox.
"This initiative marks a decisive step in connecting Indian science with industry, ensuring that innovations developed in our laboratories translate into technologies that strengthen public health and advance Viksit Bharat," said Prataprao Ganpatrao Jadhav, Union MoS, Ayush and Health and Family Welfare.
"India is moving from being a consumer of health technologies to becoming a global source of affordable and innovative healthcare solutions, powered by institutions like ICMR and strong industry partnerships," Jadhav added.
India has the scientific capability and innovation ecosystem to emerge as a global leader in health technologies, Dr Gobardhan Das, Member, NITI Aayog, said.
Medical Innovation Patent Mitra will play a crucial role in protecting intellectual property, enabling technology transfer and accelerating the journey of indigenous innovations from laboratories to society, Das added.
The 'Indian Biomedical Patent Landscape Report' and the 'Technology Compendium' were also released at the event to strengthen India's biomedical innovation, intellectual property and technology transfer ecosystem.
The event also showcased over 100 technologies in diagnostics, therapeutics and medical devices developed by ICMR institutes, researchers and startups.
— IANS
Reader Comments
Finally, some good news from the health sector! The diagnostics for Japanese Encephalitis and TB are desperately needed in our smaller towns. My cousin works in a district hospital and they still send samples to far-off labs. Hope these technologies don't get stuck in bureaucratic red tape and actually reach the people who need them. 🙏
Great step, but I'm cautiously optimistic. We've seen many such initiatives fizzle out due to lack of follow-through. The 'Technology Compendium' and patent report are welcome, but what about affordable pricing for the common man? If these vaccines and devices end up costing as much as imported ones, what's the point? Hope the government ensures they're accessible.
As someone who lost a family member to TB a few years ago, this news hits close to home. India has brilliant scientists, we just need strong bridges between labs and industry. The Minister saying "India is moving from consumer to global source of affordable healthcare" gave me goosebumps. This is the Atmanirbhar Bharat we need in healthcare! ✨
Very encouraging to see 41 technologies transferred in one go! But I wonder about the smaller startups and innovators. Big pharma companies often dominate such events. Hope the Patent Mitra initiative also helps small-scale researchers and individual inventors who have brilliant ideas but lack funding and industry connections. That's where true innovation often comes from.
We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.